For adults with heart failure, when the heart is weak and cannot pump enough blood to the rest of the body (HFrEF), FARXIGA is a prescription medicine approved to reduce the risk of cardiovascular death and hospitalization for heart failure. See more.
HEART FAILURE BASICS
What is HFrEF?
A healthy heart is a muscular pump that squeezes and relaxes to deliver blood to the body. Heart failure doesn’t mean the heart has stopped. For people with HFrEF (a type of heart failure called “reduced ejection fraction”), it means the heart muscle is weak, so it can’t pump enough blood to keep up with the body’s needs. About half of people with heart failure have HFrEF. Unlike a heart attack, heart failure happens slowly. It’s a chronic condition that gets worse over time, and can lead to hospitalization or death.
THE FACTS ON HEART FAILURE
AND WINDING UP IN THE HOSPITAL IN THE US
Almost1
million
hospitalizations a year for heart failure
1 in 8
1 in 8
deaths
a year are associated with heart failure
#1
#1
diagnosis
for going back in the hospital within a month
The statistics above reflect the total population of heart failure patients (not just those with HFrEF)
FARXIGA CAN HELP PROTECT PEOPLE WITH A TYPE OF HEART FAILURE BY



For people being treated for HFrEF:
Ask your doctor how FARXIGA can help
give you added protection
You can do something about heart failure: ask your doctor about FARXIGA. It may help reduce hospitalization for heart failure.
3 IMPORTANT QUESTIONS TO ASK:
What can FARXIGA do to help reduce my chances of going to the hospital for heart failure?
Does FARXIGA offer once-daily dosing to fit my treatment plan?
What are the possible side effects of FARXIGA?
SIGN UP FOR A $0 CO-PAY
Most commercially insured patients are eligible for a $0 co-pay. Subject to eligibility. Restrictions apply. Not available for government-insured patients.